These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9259273)

  • 1. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups.
    Marron MP; Raffel LJ; Garchon HJ; Jacob CO; Serrano-Rios M; Martinez Larrad MT; Teng WP; Park Y; Zhang ZX; Goldstein DR; Tao YW; Beaurain G; Bach JF; Huang HS; Luo DF; Zeidler A; Rotter JI; Yang MC; Modilevsky T; Maclaren NK; She JX
    Hum Mol Genet; 1997 Aug; 6(8):1275-82. PubMed ID: 9259273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33.
    Marron MP; Zeidler A; Raffel LJ; Eckenrode SE; Yang JJ; Hopkins DI; Garchon HJ; Jacob CO; Serrano-Rios M; Martinez Larrad MT; Park Y; Bach JF; Rotter JI; Yang MC; She JX
    Diabetes; 2000 Mar; 49(3):492-9. PubMed ID: 10868973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent).
    Larsen ZM; Kristiansen OP; Mato E; Johannesen J; Puig-Domingo M; de Leiva A; Nerup J; Pociot F
    Autoimmunity; 1999; 31(1):35-42. PubMed ID: 10593567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population.
    Chistiakov DA; Savost'anov KV; Nosikov VV
    BMC Genet; 2001; 2():6. PubMed ID: 11286636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody.
    Abe T; Yamaguchi Y; Takino H; Fujita N; Yamauchi-Degawa M; Ozaki M; Yamakawa K; Sera Y; Sakamaki H; Uotani S; Kawasaki E; Awata T; Yamasaki H; Eguchi K
    Diabet Med; 2001 Sep; 18(9):726-31. PubMed ID: 11606170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms.
    Holopainen PM; Partanen JA
    J Immunol; 2001 Sep; 167(5):2457-8. PubMed ID: 11509583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders.
    Naluai AT; Nilsson S; Samuelsson L; Gudjónsdóttir AH; Ascher H; Ek J; Hallberg B; Kristiansson B; Martinsson T; Nerman O; Sollid LM; Wahlström J
    Tissue Antigens; 2000 Oct; 56(4):350-5. PubMed ID: 11098935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study.
    Holopainen P; Arvas M; Sistonen P; Mustalahti K; Collin P; Mäki M; Partanen J
    Tissue Antigens; 1999 May; 53(5):470-5. PubMed ID: 10372542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population.
    McCormack RM; Maxwell AP; Carson D; Patterson CC; Bingham A; Savage DA
    Genes Immun; 2001 Jun; 2(4):233-5. PubMed ID: 11477480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a german population.
    Badenhoop K; Donner H; Pani M; Rau H; Siegmund T; Braun J
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S89-92. PubMed ID: 10522814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
    Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes.
    Turpeinen H; Laine AP; Hermann R; Simell O; Veijola R; Knip M; Ilonen J
    Eur J Immunogenet; 2003 Aug; 30(4):289-93. PubMed ID: 12919291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population.
    Ban Y; Taniyama M; Tozaki T; Yanagawa T; Yamada S; Maruyama T; Kasuga A; Tomita M; Ban Y
    Autoimmunity; 2001; 34(1):39-43. PubMed ID: 11681491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children.
    Lee YJ; Huang FY; Lo FS; Wang WC; Hsu CH; Kao HA; Yang TY; Chang JG
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):153-7. PubMed ID: 10671941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects.
    Yanagawa T; Maruyama T; Gomi K; Taniyama M; Kasuga A; Ozawa Y; Terauchi M; Hirose H; Maruyama H; Saruta T
    Autoimmunity; 1999; 29(1):53-6. PubMed ID: 10052685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.
    Dyment DA; Steckley JL; Willer CJ; Armstrong H; Sadovnick AD; Risch N; Ebers GC
    J Neuroimmunol; 2002 Feb; 123(1-2):193-8. PubMed ID: 11880164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes.
    Wood JP; Pani MA; Bieda K; Meyer G; Usadel KH; Badenhoop K
    Eur J Immunogenet; 2002 Aug; 29(4):347-9. PubMed ID: 12121283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families.
    Donner H; Seidl C; Braun J; Siegmund T; Herwig J; Seifried E; Usadel KH; Badenhoop K
    Diabetes; 1998 Jul; 47(7):1158-60. PubMed ID: 9648843
    [No Abstract]   [Full Text] [Related]  

  • 19. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.
    Van der Auwera BJ; Vandewalle CL; Schuit FC; Winnock F; De Leeuw IH; Van Imschoot S; Lamberigts G; Gorus FK
    Clin Exp Immunol; 1997 Oct; 110(1):98-103. PubMed ID: 9353155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
    Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
    Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.